Literature DB >> 27418328

Psychotic disorders in DSM-5 and ICD-11.

Falko Biedermann1, W Wolfgang Fleischhacker1.   

Abstract

The Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition (DSM-5) was published by the American Psychiatric Association (APA) in 2013, and the Work Group on the Classification of Psychotic disorders (WGPD), installed by the World Health Organization (WHO), is expected to publish the new chapter about schizophrenia and other primary psychotic disorders in 2017. We reviewed the available literature to summarize the major changes, innovations, and developments of both manuals. If available and possible, we outline the theoretical background behind these changes. Due to the fact that the development of ICD-11 has not yet been completed, the details about ICD-11 are still proposals under ongoing revision. In this ongoing process, they may be revised and therefore have to be seen as proposals. DSM-5 has eliminated schizophrenia subtypes and replaced them with a dimensional approach based on symptom assessments. ICD-11 will most likely go in a similar direction, as both manuals are planned to be more harmonized, although some differences will remain in details and the conceptual orientation. Next to these modifications, ICD-11 will provide a transsectional diagnostic criterion for schizoaffective disorders and a reorganization of acute and transient psychotic and delusional disorders. In this manuscript, we will compare the 2 classification systems.

Entities:  

Keywords:  DSM-5; Diagnostic criteria; ICD-11; psychotic disorder; schizophrenia

Mesh:

Year:  2016        PMID: 27418328     DOI: 10.1017/S1092852916000316

Source DB:  PubMed          Journal:  CNS Spectr        ISSN: 1092-8529            Impact factor:   3.790


  13 in total

1.  [Bipolar disorder vulnerability: The vitamin D path].

Authors:  Manel Naifar; Manel Maalej Bouali; Wassim Guidara; Ahmed Slim Ellouze; Khalil Jmal; Sana Omri; Meriam Messedi; Lobna Zouari; Aida Elleuch; Mohamed Maalej; Khansa Chaabouni; Nada Charfi; Mouna Turki; Ben Thabet Jihène; Fatma Ayadi
Journal:  Can J Psychiatry       Date:  2019-08-21       Impact factor: 4.356

2.  Renaming schizophrenia: benefits, challenges and barriers.

Authors:  Antonio Lasalvia; Mirella Ruggeri
Journal:  Epidemiol Psychiatr Sci       Date:  2018-11-26       Impact factor: 6.892

Review 3.  Dilemmas in the treatment of early-onset first-episode psychosis.

Authors:  Daniel Hayes; Marinos Kyriakopoulos
Journal:  Ther Adv Psychopharmacol       Date:  2018-03-26

4.  Effects of Sex on the Relationship Between Apolipoprotein E Gene and Serum Lipid Profiles in Alzheimer's Disease.

Authors:  Jiajia Fu; Yan Huang; Ting Bao; Ruwei Ou; Qianqian Wei; Yongping Chen; Jing Yang; Xueping Chen; Huifang Shang
Journal:  Front Aging Neurosci       Date:  2022-05-30       Impact factor: 5.702

5.  A Case Report of Suicide Attempt Caused by Acute and Transient Psychotic Disorder during the COVID-19 Outbreak.

Authors:  Kai Zhang; Yudong Shi; Huanzhong Liu; Kenji Hashimoto
Journal:  Case Rep Psychiatry       Date:  2020-05-27

6.  Cardio-Metabolic Indices and Metabolic Syndrome as Predictors of Clinical Severity of Gastroenteropancreatic Neuroendocrine Tumors.

Authors:  Luigi Barrea; Giovanna Muscogiuri; Roberta Modica; Barbara Altieri; Gabriella Pugliese; Roberto Minotta; Antongiulio Faggiano; Annamaria Colao; Silvia Savastano
Journal:  Front Endocrinol (Lausanne)       Date:  2021-03-18       Impact factor: 5.555

7.  Psychosis Biotypes: Replication and Validation from the B-SNIP Consortium.

Authors:  Brett A Clementz; David A Parker; Rebekah L Trotti; Jennifer E McDowell; Sarah K Keedy; Matcheri S Keshavan; Godfrey D Pearlson; Elliot S Gershon; Elena I Ivleva; Ling-Yu Huang; S Kristian Hill; John A Sweeney; Olivia Thomas; Matthew Hudgens-Haney; Robert D Gibbons; Carol A Tamminga
Journal:  Schizophr Bull       Date:  2022-01-21       Impact factor: 9.306

Review 8.  Therapeutic Potential of TAAR1 Agonists in Schizophrenia: Evidence from Preclinical Models and Clinical Studies.

Authors:  Nina Dedic; Heather Dworak; Courtney Zeni; Grazia Rutigliano; Oliver D Howes
Journal:  Int J Mol Sci       Date:  2021-12-07       Impact factor: 5.923

Review 9.  Clinical Approaches to Late-Onset Psychosis.

Authors:  Kiwon Kim; Hong Jin Jeon; Woojae Myung; Seung Wan Suh; Su Jeong Seong; Jae Yeon Hwang; Je Il Ryu; Seon-Cheol Park
Journal:  J Pers Med       Date:  2022-03-02

10.  Therapeutic Targets and Mechanism of Xingpi Jieyu Decoction in Depression: A Network Pharmacology Study.

Authors:  Ze Chang; Li-Juan He; Dang-Feng Tian; Qiang Gao; Jing-Feng Ling; Yu-Chun Wang; Zhen-Yun Han; Rong-Juan Guo
Journal:  Evid Based Complement Alternat Med       Date:  2021-06-23       Impact factor: 2.629

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.